Israël - Hebreeuws - Ministry of Health

j-c health care ltd - ibrutinib - קפסולות - ibrutinib 140 mg

Israël - Hebreeuws - Ministry of Health

j-c health care ltd - ibrutinib - טבליות מצופות פילם - ibrutinib 140 mg - ibrutinib

Israël - Hebreeuws - Ministry of Health

j-c health care ltd - ibrutinib - טבליות מצופות פילם - ibrutinib 280 mg - ibrutinib

Israël - Hebreeuws - Ministry of Health

j-c health care ltd - ibrutinib - טבליות מצופות פילם - ibrutinib 420 mg - ibrutinib

Israël - Hebreeuws - Ministry of Health

j-c health care ltd - ibrutinib - טבליות מצופות פילם - ibrutinib 560 mg - ibrutinib

Israël - Hebreeuws - Ministry of Health

אפריל רשת חנויות בעמ - איפור

Israël - Hebreeuws - Ministry of Health

גילקו פארם בעמ - ג'ל להרגעה ולהזנת העור

Israël - Hebreeuws - Ministry of Health

astrazeneca (israel) ltd - a/darwin/9/2021 (h3n2)-like virus; a/victoria/4897/2022 (h1n1)pdm09-like virus; b/austria/1359417/2021 (b/victoria lineage)-like virus; b/phuket/3073/2013 (b/yamagata lineage)-like virus - ספריי לאף - b/phuket/3073/2013 (b/yamagata lineage)-like virus 7 ±0.5 log10 ffu^a / 0.2 ml; a/darwin/9/2021 (h3n2)-like virus 7 ±0.5 log10 ffu^a / 0.2 ml; b/austria/1359417/2021 (b/victoria lineage)-like virus 7 ±0.5 log10 ffu^a / 0.2 ml; a/victoria/4897/2022 (h1n1)pdm09-like virus 7 ±0.5 log10 ffu^a / 0.2 ml - influenza, inactivated, split virus or surface antigen - influenza, purified antigen - flumist quadrivalent is a vaccine indicated for active immunization for the prevention of influenza disease caused by influenza a subtype viruses ad type b viruses contained in the vaccine. flumist quadrivalent is approved for use in persons 2 through 49 years of age.

Israël - Hebreeuws - Ministry of Health

pharmalogic ltd - cytarabine 100 mg / 5 ml - solution for injection - cytarabine - for induction and maintenance of clinical remission in patients with acute myeloid leukemia, acute non-lymphoblastic leukemias, acute lymphoblastic leukemias, blast crises of chronic myeloid leukemia, diffuse histiocytic lymphomas ( non-hodgkin's lymphomas of high malignancy).

Israël - Hebreeuws - Ministry of Health

novartis israel ltd - cytarabine - תמיסה להזרקה\אינפוזיה - cytarabine 50 mg / 1 ml - cytarabine - cytarabine - for induction and maintenance of clinical remission in patients with acute myeloid leukemia, acute non-lymphoblastic leukemias, acute lymphoblastic leukemias, blast crises of chronic myeloid leukemia, diffuse histiocytic lymphomas ( non-hodgkin's lymphomas of high malignancy).